WAVE LIFE SCIENCES LTD. Interest Income (Expense), Net
WAVE LIFE SCIENCES LTD. (WVE) reported Interest Income (Expense), Net of $86.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-30.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2016-03-30
- WAVE LIFE SCIENCES LTD. interest income (expense), net for the quarter ending 2015-12-31 was $76.00K.
- WAVE LIFE SCIENCES LTD. interest income (expense), net for the quarter ending 2015-09-30 was $25.00K.
- WAVE LIFE SCIENCES LTD. interest income (expense), net for the quarter ending 2014-12-31 was $0.00.
- WAVE LIFE SCIENCES LTD. interest income (expense), net for fiscal 2015 was $86.00K.
- WAVE LIFE SCIENCES LTD. interest income (expense), net for fiscal 2014 was -$12.00K.
- WAVE LIFE SCIENCES LTD. interest income (expense), net for fiscal 2013 was -$111.00K.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2015-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $101.00K derived: sum of 2 quarters · filed 2016-03-30 | $86.00K 10-K · filed 2016-03-30 | |
| 2015-09-30 | $25.00K 10-Q · filed 2015-12-17 | $10.00K 10-Q · filed 2015-12-17 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$12.00K 10-K · filed 2016-03-30 | ||
| 2014-09-30 | -$12.00K 10-Q · filed 2015-12-17 | |||
| 2013-12-31 | -$111.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |